Pan Tong

A pan-cancer proteomic perspective on The Cancer Genome Atlas

Rehan Akbani, Patrick Kwok Shing Ng, Henrica M.J. Werner et al. · Nature Communications · 2014 · 618 citations · Full text

Tumor Biology, Functional Genomics, Tumor Heterogeneity +8

CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade

Limo Chen, Lixia Diao, Yongbin Yang et al. · Cancer Discovery · 2018 · 457 citations

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

C. Allison Stewart, Pan Tong, Robert J. Cardnell et al. · Oncotarget · 2017 · 221 citations · Full text

Pathology, Cancer Biology, Tumor Biology +17

CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib

Triparna Sen, Pan Tong, C. Allison Stewart et al. · Cancer Research · 2017 · 189 citations

Stress hormones promote EGFR inhibitor resistance in NSCLC: Implications for combinations with β-blockers

Monique B. Nilsson, Huiying Sun, Lixia Diao et al. · Science Translational Medicine · 2017 · 147 citations · Full text